I

Ipsen Global

Global biopharma focused on specialty care

Global Marketing Director - Consumer Strategy and Market Development, Migraine

Marketing Generalist & ManagementConfirmed live in the last 24 hours
Full-timeCambridge, MA, USA

About the Job

Requirements

  • At least 10 years of progressive experience in pharmaceutical, biotechnology, or related healthcare industries.
  • Strong experience in patient or customer strategy, marketing, or market development.
  • Demonstrated experience with patient journey mapping, segmentation, and insight generation.
  • Experience supporting pharmaceutical launches or major lifecycle opportunities.
  • Global or above-country commercial experience.
  • Strong cross-functional leadership and influencing skills.
  • Experience translating patient insights into scalable global strategies and market-execution frameworks.
  • Demonstrated ability to use data, analytics, and customer insights to inform strategic commercial decisions.
  • Ability to partner effectively with analytics, data-science, digital, and technical teams without requiring direct technical ownership of model development.
  • Ability to work from the Cambridge, Massachusetts headquarters on a hybrid model, including working from the office.
  • A bachelor's degree or equivalent in a relevant field.
  • English language proficiency.

Responsibilities

  • Lead development and evolution of the global patient strategy for Dysport in migraine across chronic and episodic migraine.
  • Develop a deep understanding of patient needs, beliefs, motivations, treatment expectations, and barriers.
  • Define global patient segments based on needs, behaviors, disease burden, treatment history, and readiness for preventive treatment.
  • Establish patient behavioral objectives aligned with the broader migraine commercial strategy.
  • Develop the global patient value proposition, messaging framework, and patient-engagement principles.
  • Incorporate advanced analytics and emerging technologies into patient strategy where they improve understanding, prioritization, and decision-making.
  • Develop a comprehensive patient-focused journey strategy spanning symptom recognition, disease awareness, care seeking, diagnosis, referral, preventive-treatment consideration, treatment initiation, and persistence.
  • Identify patient drop-off points, unmet needs, and barriers across the patient journey.
  • Understand how patient beliefs, knowledge, previous treatment experience, expectations, and healthcare-system factors influence progression through the journey.
  • Identify opportunities to improve patient recognition of migraine burden and understanding of preventive-treatment options.
  • Apply patient-flow analytics and other advanced analytical approaches to identify patterns, barriers, and opportunities across the patient journey.
  • Keep patient journey strategy focused on patient needs and behaviors while collaborating with other functions on healthcare-system or healthcare-professional-dependent barriers.
  • Develop global market-development strategies to increase the number of appropriate patients reaching effective preventive migraine treatment.
  • Identify structural market-development barriers, including underdiagnosis, undertreatment, delayed care seeking, delayed referral, limited disease awareness, and inconsistent use of preventive therapy.
  • Identify opportunities to support appropriate evolution of the preventive-migraine treatment market across chronic and episodic migraine.
  • Define strategies to improve patient activation and support appropriate dialogue between patients and healthcare professionals.
  • Identify scalable opportunities to address patient-related barriers to diagnosis, referral, and preventive-treatment consideration.
  • Partner with markets to prioritize market-development opportunities based on local epidemiology, healthcare-system dynamics, treatment pathways, and patient behaviors.
  • Use advanced analytics, predictive approaches, and emerging capabilities to identify and prioritize high-value market-development opportunities.
  • Define how education, disease awareness, patient activation, and support can positively influence relevant patient behaviors.
  • Develop global patient-engagement principles that can be adapted to different regulatory and cultural environments.
  • Partner with Digital and other relevant functions to identify patient-engagement opportunities and appropriate channels.
  • Explore machine learning, artificial-intelligence-enabled analytics, and other emerging technologies to improve the relevance, precision, and effectiveness of patient engagement and activation strategies.
  • Partner with Digital, Data Science, and analytics teams to identify opportunities for tailored engagement based on patient needs, behaviors, and journey stage.
  • Ensure patient communications are grounded in patient insights and deliver relevant, understandable, and actionable information.
  • Ensure data-driven and technology-enabled patient strategies comply with applicable regulatory, privacy, legal, and compliance requirements.
  • Partner with Advocacy, Medical, and other functions to understand the perspectives and unmet needs of the migraine community.
  • Identify appropriate opportunities for disease awareness, patient education, and community engagement.
  • Support strategic engagement with patient organizations and other external stakeholders in compliance with applicable policies and regulations.
  • Incorporate patient and community insights into market-development and patient-engagement strategies.
  • Partner with Regional and Local teams to develop global-to-local patient and market-development frameworks.
  • Integrate patient strategy with brand strategy, healthcare-professional strategy, and launch planning while maintaining clear ownership of the patient audience and patient journey.
  • Work with priority markets to pressure-test global patient strategies and identify scalable execution opportunities.
  • Partner with the US organization while ensuring global patient strategies apply across diverse healthcare systems and regulatory environments.
  • Identify opportunities to pilot and scale innovative patient- and data-driven approaches across priority markets.
  • Partner with Insights & Analytics to generate patient journey, segmentation, and behavioral insights.
  • Define strategic insight-generation priorities supporting patient strategy, market development, and launch decision-making.
  • Champion advanced analytics, machine learning, and artificial-intelligence-enabled approaches to understand patient behaviors, journey progression, unmet needs, and market-development opportunities.
  • Partner with Insights & Analytics, Data Science, Digital, and other functions to identify and prioritize use cases for predictive modeling, advanced segmentation, patient-flow analysis, and other analytical approaches.
  • Define business questions, strategic requirements, and measures of success for advanced analytics and artificial-intelligence-enabled initiatives, relying on technical experts for model development and implementation.
  • Translate outputs from advanced analytics and machine-learning models into actionable commercial, patient, and market-development decisions.
  • Explore opportunities to identify patient segments, journey barriers, and market opportunities not evident through traditional research alone.
  • Lead relevant global patient market research and insight-generation initiatives.
  • Partner with Medical and Market Access to understand how clinical practice, reimbursement, policy, and healthcare-system constraints affect patient progression.
  • Monitor changes in patient behaviors, expectations, data availability, technological capabilities, and the migraine treatment environment.
  • Develop key performance indicators measuring progress against patient behavioral and market-development objectives.
  • Establish measures related to disease awareness, patient activation, diagnosis, referral, preventive-treatment consideration, and other relevant indicators.
  • Define success measures for advanced analytics and innovation initiatives based on their contribution to strategic decision-making, patient understanding, and market-development outcomes.
  • Partner with Insights & Analytics and market teams to assess effectiveness and optimize strategy.
  • Lead and manage external agencies and strategic partners supporting patient insights, market-development strategy, disease-awareness initiatives, patient communications, activation programs, analytics, and innovation initiatives.
  • Develop agency briefs and ensure external partners deliver strategically aligned, patient-centered, and high-quality work.
  • Oversee agency scopes, budgets, timelines, and performance.
  • Ensure external partners supporting data, analytics, artificial intelligence, or technology initiatives work effectively with internal technical and compliance stakeholders.

Desired Qualifications

  • Migraine, neuroscience, or specialty-care experience.
  • Experience in patient activation, disease awareness, or market shaping.
  • Experience with specialty, physician-administered therapies, neurotoxins, or biologics.
  • Experience engaging with patient advocacy organizations.
  • Familiarity with markets characterized by significant diagnosis, referral, treatment, or access barriers.
  • Experience applying advanced analytics, machine learning, artificial-intelligence-enabled segmentation, predictive modeling, or other emerging technologies to commercial, customer, or patient-strategy challenges.
  • Experience working with real-world data, patient-flow analytics, or other large healthcare datasets.
  • An MS, MBA, or other relevant advanced degree.
  • Additional languages.

About the Company

Ipsen Global

Global biopharma focused on specialty care

Ipsen is a global biopharmaceutical company that concentrates on specialty care, developing and marketing medicines for oncology, neuroscience, and rare diseases. Its products work by treating specific high-need conditions, ranging from historical diarrhea treatment Smecta to modern targeted therapies in cancer and neurological disorders. The company differentiates itself through a focused portfolio in niche therapeutic areas, growth via strategic acquisitions, and a long-standing family heritage that shaped its international expansion and IPO-driven capital for expansion. Its goal is to address unmet medical needs worldwide by providing effective therapies for patients with serious or rare conditions.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boulogne-Billancourt, France
Founded
2005

Recently Posted Jobs

Explore more opportunities at Ipsen Global

See more jobs